{"disease":{"id":"uicc-iii","name":"uicc iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03263663","title":"Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"PD Dr. med. Volker Heinemann","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}